Steve Kemler

Steve manages the Philadelphia market NetSuite team and provides NetSuite consulting services to a variety of clients in industries including life sciences, technology and wholesale distribution. Steve leads projects that require complex integrations, customizations and complex finance requirements.

As a member of RSM’s life sciences team, Steve consistently supports clients in the industry across the country. He also participates in the PACT MedTech series and is involved in multiple regional life sciences initiatives.

In May 2020, Steve was selected as a senior analyst in RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves.

5 things to know in life sciences: Week of August 16

Aug. 20, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From delta variant considerations to psychedelic-based therapeutics, each week we highlight five things to know in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of August 9

Aug. 13, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From infrastructure to drug pricing, our senior analysts highlight the latest issues affecting the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of August 2

Aug. 6, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From gene and cell therapy developments to the latest on initial public offerings, each week we highlight five things you need to know in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of July 26

Jul. 30, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From the development of an insulin biosimilar to a new tool matching mental health providers with patients, each week we highlight five things you need to know in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of July 19

Jul. 23, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From an innovative artificial intelligence app used to treat mental health issues to investment opportunities related to women’s health, each week we highlight five things you need to know in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of July 12

Jul. 15, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From new technologies contributing to the medical devices boom to the hot biotech IPO market, we highlight five things to know in the life sciences industry this week. … READ MORE >

5 things to know in life sciences: Week of June 28

Jul. 1, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From a new way to treat diabetes via an old tuberculosis vaccine to the impact on the industry of increasing patient volumes, each week we highlight the latest in life sciences. … READ MORE >

5 things to know in life sciences: Week of June 21

Jun. 25, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From a new generation of deep brain stimulation devices to using artificial intelligence to detect HIV, each week we highlight five things you need to know about in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of June 14

Jun. 18, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From tools to support decentralized clinical trials to new efforts to reduce systemic racism in medical research, each week we highlight five things you need to know about in the life sciences industry. … READ MORE >

5 things to know in life sciences: Week of June 7

Jun. 10, 2021 by Steve Kemler, Adam Lohr, David Stuart and Justin Culbertson

From the new Alzheimer’s drug, aducanumab, to a White House report on supply chain risk, we highlight the latest impacting the life sciences industry. … READ MORE >

« Previous Page